Substance / Medication

Candesartan

Overview

Active Ingredient
candesartan
RxNorm CUI
214354

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials.
Henley Brandon, Okafor Maureen, Kulshreshtha Ambar et al. · Int J Stroke · 2023
PMID: 36645213Meta-AnalysisFull text (PMC)
A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension.
Zhenfeng Zheng, Huilan Shi, Junya Jia et al. · J Renin Angiotensin Aldosterone Syst · 2011
PMID: 21421652Meta-Analysis
[Efficacy of candesartan cilexetil in hypertensive patients with or without diabetes].
El Féghali R, Nisse-Durgeat S, Asmar R · Arch Mal Coeur Vaiss · 2007
PMID: 17928776Meta-Analysis
Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials.
Féghali Ramzi E L, Nisse-Durgeat Sophie, Asmar Roland · Vasc Health Risk Manag · 2007
PMID: 17583187Meta-AnalysisFull text (PMC)
The safety and tolerability of candesartan cilexetil in CHF.
Erdmann E, George M, Voet B et al. · J Renin Angiotensin Aldosterone Syst · 2000
PMID: 11967795Meta-Analysis
Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in Humans.
Piha Mikael O W, Cajanus Kristiina, Engström Marica T et al. · Drug Metab Dispos · 2024
PMID: 39486868RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Candesartan (substance)
SNOMED CT
372512008
UMLS CUI
C0717550
RxNorm CUI
214354

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

3
Conditions
4
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.